Blood Transfusion Reactions

Similar documents
INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

Transfusion Reactions. Directed by M-azad March 2012

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Transfusion Reactions

Boot Camp Transfusion Reactions

Unit 5: Blood Transfusion

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

TRANSFUSION REACTION EVALUATION

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD

In The Name Of GOD ADVERSE REACTIONS OF TRANSFUSION

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

Blood/Blood Component Utilization and Administration Annual Compliance Education

TRANSFUSION REACTIONS

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute

Transfusion Reactions:

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting

Non-Infectious Transfusion Reactions

To provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML).

CrackCast Episode 7 Blood and Blood Components

Transfusion reactions illustrated

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS

For more information about how to cite these materials visit

Blood Transfusion. Dr Will Dooley

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

Definitions of Current SHOT Categories & What to Report

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

Blood is serious business

Transfusion Medicine Kris0ne Kra1s, M.D.

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

Investigation of Transfusion Complications

VACCINE-RELATED ALLERGIC REACTIONS

Blood Transfusion. Dr William Dooley

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority

Blood Products & Transfusion. Karim Rafaat, M.D.

Blood Bank Instructions

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Chapter 13 ADVERSE TRANSFUSION EVENTS

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component

Crossmatching and Issuing Blood Components; Indications and Effects.

Immunological transfusion reactions

In the United States, transfusion reactions are reported to occur. Global Prevalence. Evolution of Transfusion Practices

VACCINE-RELATED ALLERGIC REACTIONS

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local

Belgium. Federal State

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Learning Objectives: At the end of this exercise, the student will be able to:

NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion

Immunohematology (Introduction)

A Patient s Guide to Blood Components and Products

Future Webinars. Continuing Education 1/29/2018. February 7. February 14. February 28

Continuing Education Webinar Series

7 ADVERSE REACTIONS TO TRANSFUSION. Version July 2004, Revised 5/26/05

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

-Cardiogenic: shock state resulting from impairment or failure of myocardium

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

For platelet control as individual as you

Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE

Complications Associated With IV Therapy

BMS Education Day 28 th January and 4th February 2013

Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Blood Administration and Transfusion Reactions. This course has been awarded two (2.0) contact hours.

Transfusion Service Guidelines

QUICK REFERENCE Clinical Practice Guide on Red Blood Cell Transfusion

Transfusion reactions. Jim Taylor Haematology SpR Sheffield

Management of an immediate adverse event following immunisation

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

Principles of rational haemotherapy. Complications of blood transfusion

TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): SUMMARY RESULTS. 1 P age

Blood transfusion as a management strategy for Haemoglobinopathy. Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland

Index. Note: Page numbers of article titles are in boldface type.

Revised November 2012

5/1/2012 FRAMEWORK FOR APPROPRIATE USE AND DISTRIBUTION OF SOLVENT DETERGENT TREATED PLASMA IN CANADA

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)*

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

FRAMEWORK FOR APPROPRIATE USE AND DISTRIBUTION OF SOLVENT DETERGENT TREATED PLASMA IN CANADA

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Transfusion Associated Acute Lung Injury (TRALI)

Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc.

Information for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print

Chest diseases Hospital Laboratory Hematology Practice guidelines

ANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2.

JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION. Maggie Woods PGY-3

CSL Behring LLC Albuminar -25 US Package Insert Albumin (Human) USP, 25% Revised: 01/2008 Page 1

Transfusion Medicine Kris0ne Kra1s, M.D.

Immunocompetence The immune system responds appropriately to a foreign stimulus

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

Current Concepts Transfusion Morbidity & Mortality St. Charles Health System Grand Rounds, Bend, Oregon. Agenda. Serious Consequences of Transfusion

Brrrr, It s Cold In Here

Donor work up, follow up and ethical issues

Transfusion Therapy & Safety. Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015

Keeping track of your numbers

DATA SHEET RHESONATIV. NAME OF THE MEDICINE Rhesonativ 625 IU/mL, solution for injection

Nursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)

Transcription:

Blood Transfusion Reactions Introduction Many individuals require blood components and blood products. As per the BC Transfusion Medicine Advisory Group (BCTMAG), a blood component is at therapeutic component of blood intended for, and includes red cell, platelets, plasma, cryoprecipitate, and granulocytes. The BCTMAG describes blood products as any therapeutic product, derived from human blood or plasma, and produced by a manufacturing process, including human serum albumin, immunoglobulin preparations, and recombinant or porcine coagulation factors. Receiving any of these products may result in a. Definitions In accordance with national consensus guidelines, a is defined as an undesirable and unintended occurrence during or after the administration of any blood component/product, that could be considered to be related to the said product. Although blood s are generally safe, adverse reactions may occur for a number of different reasons. Most of the time, the reaction is mild and non-life threatening, but serious reactions do occur and require immediate treatment. Blood s can be classified based on the timing of onset (acute vs. delayed) and the pathophysiological mechanism (immune vs. non-immune related). Acute reactions occur within 24hours of the start of the, whereas delayed reactions occur more than 24hours after the start of infusion. Immune reactions typically involve antibody reactions between the donor and recipient s cells. Non-immune reactions may be caused by the properties of the different components within the stored blood. In addition, blood s may be caused by introduction of infectious organisms and secondary sepsis. The following is a table summarizing the most common blood s: Table 1. Common blood s Acute Immune ABO incompatibility Allergic reaction Anaphylaxis Acute Hemolytic Transfusion Reaction Febrile Non-Hemolytic Transfusion Reaction Transfusion-Related Acute Lung Injury Non-immune Transfusion-Associated Circulatory Overload Hypotensive Transfusion Reaction Metabolic imbalance Delayed Delayed Hemolytic Transfusion Delayed Serologic Transfusion Reaction Allo-Immunization Transfusion-associated Graft versus Host Disease Post- Purpura Infectious (HBV, HCV, HIV, EBV, CMV, syphilis, malaria, West Nile virus, lyme disease, prion

Infectious (bacterial) diseases) Iron overload IVIg asceptic meningitis The most common causes of -related deaths across all age groups in Canada are related acute lung injury, associated circulatory overload, acute haemolytic secondary to ABO incompatibility, and associated sepsis. Pathogenesis and Clinical Presentation The clinical presentation of the different types of blood s varies depending on the pathogenic mechanism. Although the same reactions can occur in both pediatric and adult populations, the frequency of occurrence varies for some conditions. Note that different s may present with similar signs and symptoms, and therefore be difficult to differentiate. The following is a table summarizing the pathogenesis and clinical presentation of the most common s: Table 2: Pathogenesis and Clinical presentation of common blood s Transfusion reaction Pathogenesis Clinical presentation Transfusion related Acute lung injury Transfusion associated circulatory overload Acute haemolytic - Leukocyte antibodies in the donor blood attack host - Associated with higher concentrations of plasma, e.g.: fresh frozen plasma - Rapid or excess volume delivery in a susceptible patient (e.g.: neonate, cardiac abnormality, delicate hemodynamic status, renal failure) - ABO incompatibility - Other RBC antigen - Within 2 to 6hrs of start of - Shortness of breath, work of breathing - Coughing - Tacchypnea, hypoxemia - Tachycardia - Bilateral pulmonary infiltrates - Within 6hours of end of - Shortness of breath, chest tightness - Cough - Headache - Tacchypnea - Tachycardia - Signs of volume overload: jugular venous distension, cardiac S 3, - Pulmonary edema - Chills, rigors

incompatibilities (eg. Rh, Duffy, Kell) Sepsis - Bacterial contamination in blood product enter recipient - Result in bacteremia and immune reaction. Delayed haemolytic Febrile nonhemolytic Allergic reaction Anaphylactic - Allo-immunization to other antigens. - Humoral and cellularmediated inflammatory reaction - Second most common type of blood in pediatric population - Inflammatory reaction resulting in release of histamine by mast cells - Most common type of blood in pediatric population - Severe allergic reaction against transfused blood - Apprehensiveness - Pain in lower back, flanks, chest, along infusion vein - Bleeding - Hemoglobinuria - Renal failure, chills, sweats - Warm or clammy skin - Vomiting - Rash - Tachycardia, tachypnea - Hypothermia, chills - Jaundice - Malaise - Back pain - Unexpected anemia, usually within first two weeks after - Onset 1-2 hours after - Chills, rigors, malaise - Headache - Nausea/ vomiting - Increase in diastolic BP - Urticarial rash - Pruritus - Nausea, vomiting - Diarrhea, abdominal cramps - Anxiety (less common) - Dyspnea (less common) - Immediate respiratory distress (seconds to minutes) - Upper airway edema obstruction - Lower airway signs and symptoms (bronchospasm, wheezing, retractions, SOB) - Loss of consciousness - Vomiting, weak pulses, with ultimately circulatory collapse

Assessment The cornerstone to the approach of most problems in medicine includes a thorough history and physical exam. This is then followed by ancillary investigations as required. Important aspects to include in the history of a patient suspected of developing a reaction include: - Confirm that the patient had recently received a blood - Constitutional symptoms, including fever, chills, sweats, decreased appetite - Elicit symptoms of difficulty breathing, such as dyspnea or wheezing - Gastrointestinal symptoms, including abdominal cramps, diarrhea, nausea, vomiting - Headache, dizziness - Past medical history: previous s and whether there were any reactions Perform a comprehensive physical exam, with particular attention to: - Vital signs: presence of hypotension, hypertension, tachycardia, tachypnea, fever >38 C and a rise of >1 C since the onset of, sudden onset hypoxemia <90% - Patient affect: anxiety, apprehension - Erythema or tenderness at IV site - Cutaneous changes: erythema, urticaria, pallor, jaundice - Appearance of urine: red or brown urine may indicate hemolysis and hemoglobinuria Investigations - ABO blood typing and cross matching: to assess donor-recipient ABO and Rh compatibility - Direct antiglobulin test (direct Coombs test): to identify immune-mediated hemolysis - Complete blood count (CBC): to assess extent of anemia, rule out DIC - Serum haptoglobin: low values suggest intravascular hemolysis - Urinalysis: look for hemoglobinuria - Serum creatinine and blood urea nitrogen (BUN): monitor renal function - Serum LDH: elevated values can be due to hemolysis Management Whenever a is suspected, it is crucial to stop the and send the blood product with its tubing to the blood bank for further testing. As with all potentially fatal reactions, initial management is aimed at establishing and maintaining a patient s ABCs. Next, reconfirm that the patient is receiving the correct product, unit/lot, and that it is destined for this specific patient. Notify the blood bank of any suspicions or errors. Finally, investigation as appropriate, including blood cultures, chest radiographs. Ensure that a member of the health care team informs the patient of what is going on. References:

Hillyer CD, Strauss RG, and Luban NLC. Handbook of Pediatric Transfusion Medicine. Elsevier Academic Press, 2004, San Diego. Dzieczkowski Jeffery S, Anderson Kenneth C, "Chapter 107. Transfusion Biology and Therapy" (Chapter). Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J: Harrison's Principles of Internal Medicine, 17e: http://www.accessmedicine.com/content.aspx?aid=2866013. Aqui N, Kuter DJ, Logdberg L, Sisson SD. Blood s [Online]. July 2010. Available from: First Consult, MD Consult [cited 16 January 2011] BC Provincial Blood Coordinating Office. Transfusion reaction education [online]. December 2011. www.pbco.ca/index.php? option=com_content&task=category&sectionid=9&id=67&itemid=49 Acknowlegements Writer: Donald Yung Resident Editor: Katryn Paquette